These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7582066)

  • 81. Are calcium antagonists of value in ameliorating the course of chronic renal disease?
    Luft FC; Johnston CI
    Kidney Int Suppl; 1992 May; 36():S114-8. PubMed ID: 1614061
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hypertension and chronic renal failure: the use of ACE inhibitors.
    Porush JG
    Am J Kidney Dis; 1998 Jan; 31(1):177-84. PubMed ID: 9428471
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Calcium antagonists and the progression of chronic renal failure.
    Epstein M
    Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):171-6. PubMed ID: 9529619
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Renal protection with the calcium antagonists.
    Neumayer HH; Kunzendorf U
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S11-8. PubMed ID: 1723449
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Protecting the residual renal function: how do ACE inhibitors and calcium antagonists compare?
    Maschio G
    Nephron; 1994; 67(3):257-62. PubMed ID: 7936013
    [No Abstract]   [Full Text] [Related]  

  • 86. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease.
    ter Wee PM; De Micheli AG; Epstein M
    Arch Intern Med; 1994 Jun; 154(11):1185-202. PubMed ID: 8203987
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease.
    Usami T; Kimura G
    Clin Exp Nephrol; 2006 Mar; 10(1):8-12. PubMed ID: 16544172
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The rationale for early management of chronic renal insufficiency.
    Muirhead N
    Nephrol Dial Transplant; 2001; 16 Suppl 7():51-6. PubMed ID: 11590258
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Can the rate of progression of chronic renal failure be altered?
    Kirkpatrick WG
    Am J Med Sci; 1990 Dec; 300(6):396-401. PubMed ID: 2264580
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effects of ACE inhibitors and calcium antagonists on progression of chronic renal disease.
    Epstein M
    Blood Press Suppl; 1995; 2():108-12. PubMed ID: 7582066
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hypertension as a risk factor for progression of chronic renal disease.
    Epstein M
    Blood Press Suppl; 1994; 1():23-8. PubMed ID: 8205294
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
    Lenz T; August P
    Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Calcium antagonists and renal protection: emerging perspectives.
    Epstein M
    J Hypertens Suppl; 1998 Sep; 16(4):S17-25. PubMed ID: 9817188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.